← Leaderboards
Suman Paul
Johns Hopkins University
$867,240
Attributed
$867,240
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $216.8K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$867,240 · 1
By mechanism
K08$867,240 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Andrea L Cox$41,369,991
- Felipe Andrade$7,256,287
- Arturo Casadevall$47,974,076
- Samuel R Denmeade$5,431,317
- Michael K Lee$23,093,996
Others in their field
Other Rising Stars on “Animal Model”
- Mari Ostendorf · University Of Washington$51,931,230
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
- Kevin Saunders · Duke University$18,106,404
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Research focus
Animal ModelAffectAntibody TherapyAntigensAntigen TargetingAntibodiesB-Cell LeukemiaBeta Chain Antigen T Cell ReceptorBindingBiochemicalBispecific AntibodiesB-LymphocytesCancer CellCancer Cell LineCancerousCancer PatientCareerCd19 GeneCellsCell SurfaceChemotherapyClinical TrialsCytometryCytotoxicity
Grant awards (4)
TCR Targeting Antibodies for the Treatment of T cell Cancers$216,810
K08 · FY2025 · CA · contact PI
TCR Targeting Antibodies for the Treatment of T cell Cancers$216,810
K08 · FY2024 · CA · contact PI
TCR Targeting Antibodies for the Treatment of T cell Cancers$216,810
K08 · FY2023 · CA · contact PI
TCR Targeting Antibodies for the Treatment of T cell Cancers$216,810
K08 · FY2022 · CA · contact PI